| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |